Diagnostik und Therapie einer VTE in der Schwangerschaft

In Mitteleuropa zählen thromboembolische Komplikationen zu den häufigsten mütterlichen Todesursachen, die in Zusammenhang mit einer Schwangerschaft auftreten können. Eine tiefe Venenthrombose mit bzw. ohne Lungenembolie kompliziert etwa jede 1000. Schwangerschaft. Häufiger als bei Nichtschwangeren sind die Beckenvenen in das Thrombosegeschehen einbezogen. Im Folgenden werden das diagnostische Vorgehen bei Verdacht auf eine Thrombose bzw. Lungenembolie und wichtige therapeutische Aspekte dargestellt.

Abstract

In Central Europe thromboembolic complications are among the most common maternal causes of death associated with pregnancy. About 1 in 1000 pregnancies is accompanied by deep vein thrombosis with or without pulmonary embolism. During pregnancy the pelvic veins are more often involved in thrombotic events than in nonpregnant women. This article presents the diagnosis of suspected thrombosis or pulmonary embolism and important therapeutic aspects.

Kernaussagen

• Jeder klinische Verdacht auf eine tiefe Venenthrombose oder Lungenembolie in der Schwangerschaft erfordert so zeitnah wie möglich eine Abklärung, sodass eine sichere Therapieentscheidung getroffen werden kann.

• Die venöse Sonografie ist in den Händen eines erfahrenen Untersuchers sicher und die diagnostische Methode der Wahl zur Bestätigung oder zum Ausschluss einer tiefen Becken- bzw. Beinvenenthrombose in der Schwangerschaft.

• Bei Lungenembolieverdacht darf der Schwangeren eine CT-Pulmonalisangiografie oder Lungenperfusionsszintigrafie nicht aufgrund der Strahlenbelastung vorenthalten werden. Allerdings sollen vor Strahlenexposition die übrigen diagnostischen Verfahren ausgeschöpft werden.

• Heparine gehen nicht transplazentar auf das ungeborene Kind über und können sicher in der Schwangerschaft angewandt werden. Orale Antikoagulanzien (DOAK, VKA) sind plazentagängig und potenziell teratogen und sollen daher in der Schwangerschaft nicht zur Behandlung venöser Thromboembolien eingesetzt werden.

• In der Stillzeit gelten Heparine, Fondaparinux und Vitamin-K-Antagonisten als unbedenklich.

Schlüsselwörter

tiefe Venenthrombose - Lungenembolie - Schwangerschaft - Diagnose - Therapie

Keywords

deep vein thrombosis - pulmonary embolism - pregnancy - diagnosis - therapy

Publikationsverlauf

Artikel online veröffentlicht:
18. Oktober 2023

• Literatur

• 1 Kourlaba G, Relakis J, Kontodimas S. et al. A systematic review and meta-analysis of the epidemiology and burden of venous thromboembolism among pregnant women. Int J Gynaecol Obstet 2016; 132: 4-10
• 2 Virkus RA, Løkkegaard ECL, Bergholt T. et al. Venous thromboembolism in pregnant and puerperal women in Denmark 1995–2005. A national cohort study. Thromb Haemost 2011; 106: 304-309
• 3 Abdul Sultan A, Grainge MJ, West J. et al. Impact of risk factors on the timing of first postpartum venous thromboembolism: a population-based cohort study from England. Blood 2014; 124: 2872-2880
• 4 Kamel H, Navi BB, Sriram N. et al. Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med 2014; 370: 1307-1315
• 5 Chan W-S, Spencer FA, Ginsberg JS. Anatomic distribution of deep vein thrombosis in pregnancy. CMAJ 2010; 182: 657-660
• 6 Jerjes-Sánchez C, Rodriguez D, Farjat AE. et al. Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE. TH Open 2021; 5: e24-e34
• 7 Hart C, Bauersachs R, Scholz U. et al. Prevention of Venous Thromboembolism during Pregnancy and the Puerperium with a Special Focus on Women with Hereditary Thrombophilia or Prior VTE-Position Paper of the Working Group in Women’s Health of the Society of Thrombosis and Haemostasis (GTH). Hamostaseologie 2020; 40: 572-590
• 8 Hart C, Linnemann B. Medikamentöse Thromboseprophylaxe in der Schwangerschaft. Phlebologie 2023; 52: 140-149
• 9 Miyakis S, Lockshin MD, Atsumi T. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306
• 10 Abbasi N, Balayla J, Laporta DP. et al. Trends, risk factors and mortality among women with venous thromboembolism during labour and delivery: a population-based study of 8 million births. Arch Gynecol Obstet 2014; 289: 275-284
• 11 Henriksson P, Westerlund E, Wallén H. et al. Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study. BMJ 2013; 346: e8632
• 12 Chan WS, Lee A, Spencer FA. et al. Predicting deep venous thrombosis in pregnancy: out in “LEFt” field?. Ann Intern Med 2009; 151: 85-92
• 13 Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J. et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018; 39: 3165-3241
• 14 Kline JA, Richardson DM, Than MP. et al. Systematic review and meta-analysis of pregnant patients investigated for suspected pulmonary embolism in the emergency department. Acad Emerg Med 2014; 21: 949-959
• 15 Konstantinides SV, Meyer G, Becattini C. et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 2020; 41: 543-603
• 16 Righini M, Jobic C, Boehlen F. et al. Predicting deep venous thrombosis in pregnancy: external validation of the LEFT clinical prediction rule. Haematologica 2013; 98: 545-548
• 17 Le Moigne E, Genty C, Meunier J. et al. Validation of the LEFt score, a newly proposed diagnostic tool for deep vein thrombosis in pregnant women. Thromb Res 2014; 134: 664-667
• 18 Linnemann B, Bauersachs R, Rott H. et al. Diagnosis of pregnancy-associated venous thromboembolism – position paper of the Working Group in Women’s Health of the Society of Thrombosis and Haemostasis (GTH). VASA 2016; 45: 87-101
• 19 Bellesini M, Robert-Ebadi H, Combescure C. et al. D-dimer to rule out venous thromboembolism during pregnancy: A systematic review and meta-analysis. J Thromb Haemost 2021;
• 20 van der Pol LM, Tromeur C, Bistervels IM. et al. Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism. N Engl J Med 2019; 380: 1139-1149
• 21 Linnemann B, Blank W, Doenst T. et al. AWMF-S2k-Leitlinie: Medizinische Kompressionstherapie der Extremitäten mit Medizinischem Kompressionsstrumpf (MKS), Phlebologischem Kompressionsverband (PKV) und Medizinischen adaptiven Kompressionssystemen (MAK) [AWMF-Registernummer: 037/005].
• 22 Le Gal G, Kercret G, Ben Yahmed K. et al. Diagnostic value of single complete compression ultrasonography in pregnant and postpartum women with suspected deep vein thrombosis: prospective study. BMJ 2012; 344: e2635
• 23 Chan WS, Spencer FA, Lee AYY. et al. Safety of withholding anticoagulation in pregnant women with suspected deep vein thrombosis following negative serial compression ultrasound and iliac vein imaging. CMAJ 2013; 185: E194-200
• 24 Ray JG, Vermeulen MJ, Bharatha A. et al. Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes. JAMA 2016; 316: 952-961
• 25 Wang PI, Chong ST, Kielar AZ. et al. Imaging of pregnant and lactating patients: part 1, evidence-based review and recommendations. AJR Am J Roentgenol 2012; 198: 778-784
• 26 Masselli G, Brunelli R, Casciani E. et al. Acute abdominal and pelvic pain in pregnancy: MR imaging as a valuable adjunct to ultrasound?. Abdom Imaging 2011; 36: 596-603
• 27 Sundgren PC, Leander P. Is administration of gadolinium-based contrast media to pregnant women and small children justified?. J Magn Reson Imaging 2011; 34: 750-757
• 28 Webb JAW, Thomsen HS, Morcos SK. The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol 2005; 15: 1234-1240
• 29 Amin R, Darrah T, Wang H. et al. Editor’s Highlight: In Utero Exposure to Gadolinium and Adverse Neonatal Outcomes in Premature Infants. Toxicol Sci 2017; 156: 520-526
• 30 Righini M, Robert-Ebadi H, Elias A. et al. Diagnosis of Pulmonary Embolism During Pregnancy: A Multicenter Prospective Management Outcome Study. Ann Intern Med 2018; 169: 766-773
• 31 Tromeur C, van der Pol LM, Le Roux P-Y. et al. Computed tomography pulmonary angiography versus ventilation-perfusion lung scanning for diagnosing pulmonary embolism during pregnancy: a systematic review and meta-analysis. Haematologica 2019; 104: 176-188
• 32 Leung AN, Bull TM, Jaeschke R. et al. American Thoracic Society documents: an official American Thoracic Society/Society of Thoracic Radiology Clinical Practice Guideline--Evaluation of Suspected Pulmonary Embolism in Pregnancy. Radiology 2012; 262: 635-646
• 33 Tremblay E, Thérasse E, Thomassin-Naggara I. et al. Quality initiatives: guidelines for use of medical imaging during pregnancy and lactation. Radiographics 2012; 32: 897-911
• 34 Herédia V, Altun E, Ramalho M. et al. MRI of pregnant patients for suspected pulmonary embolism: steady-state free precession vs postgadolinium 3D-GRE. Acta Med Port 2012; 25: 359-367
• 35 Hüttel E, Padberg S, Meister R. et al. Pregnancy outcome of first trimester exposure to the vitamin K antagonist phenprocoumon depends on duration of treatment. Thromb Haemost 2017; 117: 870-879
• 36 Beyer-Westendorf J, Tittl L, Bistervels I. et al. Safety of direct oral anticoagulant exposure during pregnancy: a retrospective cohort study. The Lancet Haematology 2020; 7: e884-e891
• 37 Jacobson B, Rambiritch V, Paek D. et al. Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic Review and Meta-Analysis. Adv Ther 2020; 37: 27-40
• 38 Bauersachs RM, Dudenhausen J, Faridi A. et al. Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women. Thromb Haemost 2007; 98: 1237-1245
• 39 Gándara E, Carrier M, Rodger MA. Management of pregnancy associated venous-thromboembolism: a survey of practices. Thromb J 2014; 12: 12
• 40 Patel JP, Green B, Patel RK. et al. Population pharmacokinetics of enoxaparin during the antenatal period. Circulation 2013; 128: 1462-1469
• 41 Bates SM, Greer IA, Middeldorp S. et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e691S-e736S
• 42 Linnemann B, Scholz U, Rott H. et al. Treatment of pregnancy-associated venous thromboembolism – position paper from the Working Group in Women’s Health of the Society of Thrombosis and Haemostasis (GTH). VASA 2016; 45: 103-118
• 43 Garcia DA, Baglin TP, Weitz JI. et al. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e24S-e43S
• 44 Hart C, Rott H, Heimerl S. et al. Management of Antithrombin Deficiency in Pregnancy. Hamostaseologie 2022; 42: 320-329
• 45 Lindhoff-Last E, Kreutzenbeck H-J, Magnani HN. Treatment of 51 pregnancies with danaparoid because of heparin intolerance. Thromb Haemost 2005; 93: 63-69
• 46 Elsaigh E, Thachil J, Nash MJ. et al. The use of fondaparinux in pregnancy. Br J Haematol 2015; 168: 762-764
• 47 Linkins L-A, Dans AL, Moores LK. et al. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e495S-e530S
• 48 Schindewolf M, Gobst C, Kroll H. et al. High incidence of heparin-induced allergic delayed-type hypersensitivity reactions in pregnancy. J Allergy Clin Immunol 2013; 132: 131-139
• 49 Ludwig RJ, Schindewolf M, Alban S. et al. Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides. Thromb Haemost 2005; 94: 1265-1269
• 50 Dempfle C-EH. Minor transplacental passage of fondaparinux in vivo. N Engl J Med 2004; 350: 1914-1915
• 51 Blondon M, Martinez de Tejada B, Glauser F. et al. Management of high-risk pulmonary embolism in pregnancy. Thromb Res 2021; 204: 57-65
• 52 Chan W-S, Rey E, Kent NE. et al. Venous Thromboembolism and Antithrombotic Therapy in Pregnancy. Journal of Obstetrics and Gynaecology Canada 2014; 36: 527-553
• 53 Martillotti G, Boehlen F, Robert-Ebadi H. et al. Treatment options for severe pulmonary embolism during pregnancy and the postpartum period: a systematic review. J Thromb Haemost 2017; 15: 1942-1950
• 54 Hobohm L, Keller K, Valerio L. et al. Fatality rates and use of systemic thrombolysis in pregnant women with pulmonary embolism. ESC Heart Fail 2020; 7: 2365-2372
• 55 Kaso ER, Pan JA, Salerno M. et al. Venoarterial Extracorporeal Membrane Oxygenation for Acute Massive Pulmonary Embolism: a Meta-Analysis and Call to Action. J Cardiovasc Transl Res 2021;
• 56 Herrera S, Comerota AJ, Thakur S. et al. Managing iliofemoral deep venous thrombosis of pregnancy with a strategy of thrombus removal is safe and avoids post-thrombotic morbidity. J Vasc Surg 2014; 59: 456-464
• 57 Bloom AI, Farkas A, Kalish Y. et al. Pharmacomechanical catheter-directed thrombolysis for pregnancy-related iliofemoral deep vein thrombosis. J Vasc Interv Radiol 2015; 26: 992-1000
• 58 Greer IA. Thrombosis in pregnancy: updates in diagnosis and management. Hematology Am Soc Hematol Educ Program 2012; 2012: 203-207
• 59 Limmer JS, Grotegut CA, Thames E. et al. Postpartum wound and bleeding complications in women who received peripartum anticoagulation. Thromb Res 2013; 132: e19-23
• 60 Limone BL, Hernandez AV, Michalak D. et al. Timing of recurrent venous thromboembolism early after the index event: a meta-analysis of randomized controlled trials. Thromb Res 2013; 132: 420-426
• 61 Harris SA, Velineni R, Davies AH. Inferior Vena Cava Filters in Pregnancy: A Systematic Review. J Vasc Interv Radiol 2016; 27: 354-360.e8
• 62 Thomsen AJ, Greer IA. Thromboembolic disease in pregnancy and the puerperium: acute management (Green-top guideline no. 37b). Royal College of Obstetricians and Gynaecologists 2015; 1-32
• 63 AWMF-S1-Leitlinie. Rückenmarksnahe Regionalanästhesien und Thrombembolieprophylaxe/ antithrombotische Medikation. Zugriff am 06. November 2022 unter: https://www.awmf.org/uploads/tx_szleitlinien/001–005l_S1_Rueckenmarksnahe-Regionalanaesthesien-Thrombembolieprophylaxe-antithrombotische-Medikation_2021–10_1.pdf
• 64 Daei M, Khalili H, Heidari Z. Direct oral anticoagulant safety during breastfeeding: a narrative review. Eur J Clin Pharmacol 2021; 77: 1465-1471
• 65 Appelen D, van Loo E, Prins MH. et al. Compression therapy for prevention of post-thrombotic syndrome. Cochrane Database Syst Rev 2017; 9: CD004174
• 66 Brandjes DPM, Büller HR, Heijboer H. et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. The Lancet 1997; 349: 759-762
• 67 Prandoni P, Lensing AWA, Prins MH. et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med 2004; 141: 249-256
• 68 Amin EE, Bistervels IM, Meijer K. et al. Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis. Blood 2018; 132: 2298-2304
• 69 Jayaraj A, Meissner M. Impact of graduated compression stockings on the prevention of post-thrombotic syndrome – results of a randomized controlled trial. Phlebology 2015; 30: 541-548
• 70 Arpaia G, Cimminiello C, Mastrogiacomo O. et al. Efficacy of elastic compression stockings used early or after resolution of the edema on recanalization after deep venous thrombosis: the COM.PRE Trial. Blood Coagul Fibrinolysis 2007; 18: 131-137
• 71 Partsch H, Blättler W. Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin. J Vasc Surg 2000; 32: 861-869
• 72 Prandoni P, Noventa F, Quintavalla R. et al. Thigh-length versus below-knee compression elastic stockings for prevention of the postthrombotic syndrome in patients with proximal-venous thrombosis: a randomized trial. Blood 2012; 119: 1561-1565